The role of striatal metabotropic glutamate receptors in degeneration of dopamine neurons: Review article

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Amino Acids

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00726-001-0129-zPMID 12373538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Subcellular Localization of mGluR1a and mGluR5 in the Rat and Monkey Substantia Nigra

  2001cited by this paper
• Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes

  2001cited by this paper
• Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats.

  2001cited by this paper
• Changes in the gene expression of GABA(A) receptor alpha1 and alpha2 subunits and metabotropic glutamate receptor 5 in the basal ganglia of the rats with unilateral 6-hydroxydopamine lesion and embryonic mesencephalic grafts.

  2001cited by this paper
• Changes in the Gene Expression of GABAA Receptor α1 and α2 Subunits and Metabotropic Glutamate Receptor 5 in the Basal Ganglia of the Rats with Unilateral 6-Hydroxydopamine Lesion and Embryonic Mesencephalic Grafts

  2001cited by this paper
• Effects of lubeluzole on the methamphetamine‐induced increase in extracellular glutamate and the long‐term depletion of striatal dopamine

  2001cited by this paper
• Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+‐induced neurotoxicity along with brain‐derived neurotrophic factor induction

  2001cited by this paper
• mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.

  2001cited by this paper
• Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons.

  2001influential reference
• Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine.

  2000cited by this paper
• Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra.

  2000cited by this paper
• Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective.

  2000cited by this paper
• Activation of Group II Metabotropic Glutamate Receptors Inhibits Synaptic Excitation of the Substantia Nigra Pars Reticulata

  2000cited by this paper
• Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death.

  2000influential reference
• Activation of Metabotropic Glutamate Receptor 5 Has Direct Excitatory Effects and Potentiates NMDA Receptor Currents in Neurons of the Subthalamic Nucleus

  2000cited by this paper
• Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.

  2000cited by this paper
• Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil.

  2000cited by this paper
• Neuroprotection against hypoxic/hypoglycaemic injury after the insult by the group III metabotropic glutamate receptor agonist (R,S)‐4‐phosphonophenylglycine

  2000cited by this paper
• Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration.

  2000cited by this paper
• Selective mGluR5 antagonists MPEP and SIB‐1893 decrease NMDA or glutamate‐mediated neuronal toxicity through actions that reflect NMDA receptor antagonism

  2000cited by this paper
• N‐methyl‐D‐aspartate but not glutamate induces the release of hydroxyl radicals in the neonatal rat: Modulation by group I metabotropic glutamate receptors

  2000cited by this paper
• Differential distribution of metabotropic glutamate receptor subtype mRNAs in the thalamus of the rat.

  2000cited by this paper
• Glutamate-mediated neuroprotection against N-methyl-D-aspartate toxicity: a role for metabotropic glutamate receptors.

  2000cited by this paper
• Methamphetamine selectively alters brain glutathione.

  2000cited by this paper
• Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.

  2000influential reference
• Group I and Group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection

  2000cited by this paper
• Inhibitory glutamatergic regulation of evoked dopamine release in striatum.

  2000cited by this paper
• Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases.

  2000cited by this paper
• Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors.

  1999cited by this paper
• On the relationship between extracellular glutamate, hyperexcitation and neurodegeneration, in vivo.

  1999cited by this paper
• mGluR7‐like metabotropic glutamate receptors inhibit NMDA‐mediated excitotoxicity in cultured mouse cerebellar granule neurons

  1999cited by this paper
• Metabotropic glutamate receptor modulation of excitotoxicity in the neostriatum: role of calcium channels.

  1999cited by this paper
• Protective effect of group I metabotropic glutamate receptor activation against hypoxic/hypoglycemic injury in rat hippocampal slices: timing and involvement of protein kinase C.

  1999cited by this paper
• Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury.

  1999cited by this paper
• (1S,3R)-ACPD, a metabotropic glutamate receptor agonist, enhances damage after global ischaemia.

  1999cited by this paper
• Group I Metabotropic Glutamate Receptors at GABAergic Synapses in Monkeys

  1999cited by this paper
• LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia.

  1999cited by this paper
• On the relationship between extracellular glutamate, hyperexcitation and neurodegeneration, in vivo.

  1999cited by this paper
• Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia

  1999cited by this paper
• Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795.

  1999cited by this paper
• Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms.

  1999influential reference
• Group I mGlu receptor modulation of dopamine release in the rat striatum in vivo.

  1999cited by this paper
• Expression of metabotropic glutamate receptor 1 isoforms in the substantia nigra pars compacta of the rat.

  1998cited by this paper
• Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats.

  1998cited by this paper
• Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons.

  1998cited by this paper
• Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine.

  1998cited by this paper
• Invited Review Free radicals and the pathobiology of brain dopamine systems

  1998cited by this paper
• The Activation of Metabotropic Glutamate Receptors Protects Nerve Cells from Oxidative Stress

  1998cited by this paper
• Methamphetamine causes lipid peroxidation and an increase in superoxide dismutase activity in the rat striatum.

  1998cited by this paper
• Regulation of striatal dopamine release by metabotropic glutamate receptors

  1998influential reference
• Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia

  1998cited by this paper
• Metabotropic glutamate receptors depress glutamate‐mediated synaptic input to rat midbrain dopamine neurones in vitro

  1998influential reference
• Pharmacology and functions of metabotropic glutamate receptors.

  1997cited by this paper
• Activation of the metabotropic glutamate receptor mGluR5 prevents glutamate toxicity in primary cultures of cerebellar neurons.

  1997cited by this paper
• Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody.

  1996cited by this paper
• Metabotropic glutamate receptor activation selectively limits excitotoxic damage in the intact neostriatum.

  1996cited by this paper
• The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations.

  1996cited by this paper
• Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice.

  1996cited by this paper
• Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson' disease

  1995cited by this paper
• Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons

  1995cited by this paper
• Estimating Hydroxyl Radical Content in Rat Brain Using Systemic and Intraventricular Salicylate: Impact of Methamphetamine

  1995cited by this paper
• Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.

  1994cited by this paper
• Methamphetamine‐induced neurotoxicity: Roles for glutamate and dopamine efflux

  1994cited by this paper
• The role of excitatory amino acids in experimental models of Parkinson's disease

  1994cited by this paper
• Acute Regulation of Synaptic Transmission by Metabotropic Glutamate Receptors

  1994cited by this paper
• Anatomical Distribution of Metabotropic Glutamate Receptors in Mammalian Brain

  1994influential reference
• A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord

  1993cited by this paper
• Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.

  1992cited by this paper
• Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input.

  1992cited by this paper
• The release of dopamine from nerve terminals and dendrites of nigrostriatal neurons induced by excitatory amino acids in the conscious rat

  1992cited by this paper
• Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice.

  1990cited by this paper
• Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

  1989cited by this paper
• Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain.

  1982cited by this paper
• GLUTAMATE‐INDUCED NEURONAL NECROSIS IN THE INFANT MOUSE HYPOTHALAMUS: An Electron Microscopic Study

  1971cited by this paper

• The role of metabotropic glutamate receptors in neurobehavioral effects associated with methamphetamine use.

  2023cites this paper
• N-Acetyl-Aspartyl-Glutamate in Brain Health and Disease

  2022cites this paper
• Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson’s disease: a systematic review and meta-analysis

  2021cites this paper
• Neuroprotective Properties of Glutamate Metabotropic Glutamate Receptors in Parkinson’s Disease and Other Brain Disorders

  2017cites this paper
• Deletion of Type 2 Metabotropic Glutamate Receptor Decreases Sensitivity to Cocaine Reward in Rats.

  2017cites this paper
• The role of laterodorsal tegmental acetylchone in neurochemical and behavioral measures of methamphetamine reward

  2012cites this paper
• The molecular interaction between the glutamatergic, noradrenergic, dopaminergic and serotoninergic systems informs a detailed genetic perspective on depressive phenotypes.

  2011cites this paper
• Effects of Caffeine in Parkinson's Disease: From Neuroprotection to the Management of Motor and Non-Motor Symptoms

  2010cites this paper
• Group I metabotropic glutamate receptor signalling and its implication in neurological disease.

  2010cites this paper
• Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease.

  2010cites this paper
• Birth, life and death of dopaminergic neurons in the substantia nigra.

  2009cites this paper
• Phenotype, compartmental organization and differential vulnerability of nigral dopaminergic neurons.

  2009cites this paper
• Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease.

  2009cites this paper
• A Review of Glutamate Receptors II: Pathophysiology and Pathology

  2008cites this paper
• Metabotropic glutamate receptors

  2007cites this paper
• Excitotoxicity.

  2007cites this paper
• Simultaneous detection of L-glutamate and nitric oxide from adherently growing cells at known distance using disk shaped dual electrodes.

  2007cites this paper
• Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP.

  2006cites this paper
• Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator.

  2006cites this paper
• REDOX PROTEOMICS IDENTIFICATION OF OXIDATIVELY MODIFIED PROTEINS AND THEIR PHARMACOLOGICAL MODULATION: INSIGHT INTO OXIDATIVE STRESS IN BRAIN AGING, AGE-RELATED COGNITIVE IMPAIRMENT

  2005cites this paper
• Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors.

  2005cites this paper
• The Spontaneously Hypertensive Rat as a Model of Attention Deficit Hyperactivity Disorder

  2005cites this paper
• MPEP, mGlu5 receptor antagonist, regulates NPYmRNA expression in hippocampal and amygdalar neurons.

  2004cites this paper
• Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder--the spontaneously hypertensive rat.

  2003cites this paper
• Neurobiology of Aging Xxx (2005) Xxx–xxx

  year unknowncites this paper